GLP-1 receptor activation promotes insulin secretion in response to meals, suppresses glucagon release, slows gastric emptying, and reduces appetite by acting on satiety centres in the brain
Healthier employees, however, are less likely to miss workand they're more likely to be productive when present
When will retatrutide be available
Retatrutide: The Phase 2 Trial Retatrutides most prominent data comes from a Phase 2 dose-finding trial published in the New England Journal of Medicine in 2023
Prescription medication only available if prescribed after an online consultation with a healthcare provider
Clinical trials show that higher-protein diets lead to greater fat loss and better preservation of lean tissue versus standard-protein diets, and they often make it easier to stick to a reduced-calorie plan by keeping you fuller longer